The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...
Whether you’re having dinner with friends or you’re enjoying a family gathering, the last thing you want at the end of it is heartburn. That burning pain in your chest can take the fun out of the ...
Ever felt an uncomfortable tightness or pain in your chest after a big bowl of chili or spicy takeout? It could be heartburn, which occurs when the acid in your stomach sloshes back up into your ...
Phathom Pharmaceuticals launched its first broadcast direct-to-consumer (DTC) campaign to promote Voquezna, its treatment for all severities of erosive gastroesophageal reflux disease (GERD), ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Phathom Pharmaceuticals’ Voquezna tablets 10 mg and 20 mg to treat erosive esophagitis, or ...
VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a significant and rapid reduction of heartburn with daily treatment VOQUEZNA represents the first major innovation in ...
Heartburn is not always harmless. Learn when GERD needs medical attention, its warning signs, complications, and when to ...
November 25, 2024 (Houston Style Magazine) — Millions of Americans experience the discomfort of acid reflux, and let’s be honest—nothing ruins a big meal faster than that fiery sensation creeping up ...
The Futura Team represents the pulse of Futura’s editorial department, bringing together a collective expertise dedicated to the dissemination of scientific knowledge. Rather than the work of a single ...
HEARTBURN could be masking cancers that are becoming more deadly due to diagnosis delays, warn experts. As many as four in 10 people get indigestion or acid reflux and for most it is nothing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results